NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

“This approval enables access to the approved Mounjaro pen in a more convenient presentation of a month’s treatment, of one dose per week ... s GLP-1 agonist Wegovy (semaglutide), which ...

"We are experiencing a temporary supply disruption with the Ozempic 1 mg (injection) pen due to the combination ... August to early October. The lower-dose Ozempic injection pens of 0.25 mg ...

An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions ...

A major analysis of more than 1.2 million medical records has found popular diabetes and weight loss drugs, including Ozempic and Wegovy, may also reduce the risk of other health issues.

Clothing brands are among the businesses benefiting from the GLP-1 boom as users treat their slimmer selves Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...

COPENHAGEN--Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb. 22 ... for a 0.25-milligram starter dose and 42,960 yen for a 2.4 mg dose, Novo said.

Rybelsus is taken by mouth once per day ... pocket. Wegovy is an injectable medication that contains semaglutide, the same active ingredient as Ozempic, but in a slightly higher dose.